BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 21697218)

  • 1. Development of ovarian hyperstimulation syndrome: interrogation of key proteins and biological processes in human follicular fluid of women undergoing in vitro fertilization.
    Jarkovska K; Kupcova Skalnikova H; Halada P; Hrabakova R; Moos J; Rezabek K; Gadher SJ; Kovarova H
    Mol Hum Reprod; 2011 Nov; 17(11):679-92. PubMed ID: 21697218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteome mining of human follicular fluid reveals a crucial role of complement cascade and key biological pathways in women undergoing in vitro fertilization.
    Jarkovska K; Martinkova J; Liskova L; Halada P; Moos J; Rezabek K; Gadher SJ; Kovarova H
    J Proteome Res; 2010 Mar; 9(3):1289-301. PubMed ID: 20058866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Follicular fluid levels of vascular endothelial growth factor. Are they predictive markers for ovarian hyperstimulation syndrome?
    Geva E; Amit A; Lessing JB; Lerner-Geva L; Daniel Y; Yovel I; Azem F; Barak V
    J Reprod Med; 1999 Feb; 44(2):91-6. PubMed ID: 10853438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocrine gland-derived vascular endothelial growth factor concentrations in follicular fluid and serum may predict ovarian hyperstimulation syndrome in women undergoing controlled ovarian hyperstimulation.
    Gao MZ; Zhao XM; Sun ZG; Hong Y; Zhao LW; Zhang HQ
    Fertil Steril; 2011 Feb; 95(2):673-8. PubMed ID: 21067720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Follicular fluid and serum concentrations of PAPP-A in OHSS risk group of women undergoing IVF stimulation].
    Rezábek K; Moosová M; Pavelková J; Moos J; Filová V
    Ceska Gynekol; 2009 Apr; 74(2):80-4. PubMed ID: 19514652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of cabergoline on folicular microenviroment profile in patients with high risk of OHSS.
    Guvendag Guven ES; Dilbaz S; Duraker R; Mentese A; Cinar O; Ozdegirmenci O
    Gynecol Endocrinol; 2013 Aug; 29(8):749-53. PubMed ID: 23741965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of 'coasting' on follicular fluid concentrations of vascular endothelial growth factor in women at risk of developing ovarian hyperstimulation syndrome.
    Tozer AJ; Iles RK; Iammarrone E; Gillott CM; Al-Shawaf T; Grudzinskas JG
    Hum Reprod; 2004 Mar; 19(3):522-8. PubMed ID: 14998945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different protein expression patterns associated with polycystic ovary syndrome in human follicular fluid during controlled ovarian hyperstimulation.
    Dai G; Lu G
    Reprod Fertil Dev; 2012; 24(7):893-904. PubMed ID: 22935150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Function of vascular endothelial growth factor in ovarian hyperstimulation syndrome].
    Liang W; Chen S; Xing F
    Zhonghua Fu Chan Ke Za Zhi; 2001 Nov; 36(11):651-3. PubMed ID: 11930687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of follicular fluid and serum levels of Inhibin A and Inhibin B with calculated indices used as predictive markers of Ovarian Hyperstimulation Syndrome in IVF patients.
    Moos J; Rezabek K; Filova V; Moosova M; Pavelkova J; Peknicova J
    Reprod Biol Endocrinol; 2009 Aug; 7():86. PubMed ID: 19703287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A relation between the polycystic ovary syndrome and the status of ovarian hyperstimulation syndrome in IVF patients after controlled hyperstimulation].
    Moosová M; Moos J; Filová V; Pavelková J; Jarosová R; Rezábek K
    Ceska Gynekol; 2011 Apr; 76(2):123-7. PubMed ID: 21649996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age dependent assessment of TFPI levels in follicular fluid of women undergoing IVF.
    Thyzel E; Siegling S; Tinneberg HR; Götting C; Kleesiek K
    Clin Chim Acta; 2005 Nov; 361(1-2):176-81. PubMed ID: 15993393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-18 is high in the serum of IVF pregnancies with ovarian hyperstimulation syndrome.
    Gutman G; Soussan-Gutman L; Malcov M; Lessing JB; Amit A; Azem F
    Am J Reprod Immunol; 2004 May; 51(5):381-4. PubMed ID: 15212675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concentration of soluble urokinase plasminogen activator receptor (suPAR) in the pre-ovulatory follicular fluid is associated with development of ovarian hyperstimulation syndrome during ovarian stimulation.
    Grynnerup AG; Toftager M; Zedeler A; Bogstad JW; Prætorius L; Grøndahl ML; Yding Andersen C; Sørensen S; Pinborg A; Løssl K
    J Assist Reprod Genet; 2018 Dec; 35(12):2187-2193. PubMed ID: 30232642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of ovarian hyperstimulation syndrome in women undergoing in vitro fertilization.
    Kahnberg A; Enskog A; Brännström M; Lundin K; Bergh C
    Acta Obstet Gynecol Scand; 2009; 88(12):1373-81. PubMed ID: 19878052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of CD11c+HLA-DR+dendritic cells and related cytokines in the follicular fluid might be related to pathogenesis of ovarian hyperstimulation syndrome.
    Shi SL; Peng ZF; Yao GD; Jin HX; Song WY; Yang HY; Xue RY; Sun YP
    Int J Clin Exp Pathol; 2015; 8(11):15133-7. PubMed ID: 26823856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The optimal length of 'coasting protocol' in women at risk of ovarian hyperstimulation syndrome undergoing in vitro fertilization.
    Nardo LG; Cheema P; Gelbaya TA; Horne G; Fitzgerald CT; Pease EH; Brison DR; Lieberman BA
    Hum Fertil (Camb); 2006 Sep; 9(3):175-80. PubMed ID: 17008270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A proteomic analysis identifies candidate early biomarkers to predict ovarian hyperstimulation syndrome in polycystic ovarian syndrome patients.
    Wu L; Sun Y; Wan J; Luan T; Cheng Q; Tan Y
    Mol Med Rep; 2017 Jul; 16(1):272-280. PubMed ID: 28534980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Proteomics of follicular fluid in mature human follicles and antral follicles: a comparative study with laser desorption/ionization-time of flight-mass spectrometry].
    Li L; Xing FQ; Chen SL; Sun L; Li H
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Feb; 28(2):275-8. PubMed ID: 18250062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic analysis of human follicular fluid using an alternative bottom-up approach.
    Hanrieder J; Nyakas A; Naessén T; Bergquist J
    J Proteome Res; 2008 Jan; 7(1):443-9. PubMed ID: 18047273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.